X-linked ichthyosis is no "cure." One of the aims of treatment is to reduce scaling by removing the excess, flaky scales, and keep the skin hydrated. This can be achieved using a variety of topical creams. Research is ongoing with regard to the use of gene therapy to treat XLI. In the 1960s, recessive x-linked ichthyosis was distinguished clinically from other ichthyoses. The Ichthyosis Support Group - http://www.ichthyosis.org.uk. X-linked ichthyosis X-linked ichthyosis (XLI) (also known as ") is a skin condition caused by the hereditary deficiency of the steroid sulfatase (STS) enzyme that affects 1 in 2000 to 1 in 6000 males.
Body fluid or blood-borne diseases. Universal precautions and safer sex practices try to avoid exchanges of body fluids. Body fluids can be analyzed in medical laboratory in order to find microbes, inflammation, cancers, etc. Clinical samples are generally defined as non-infectious human or animal materials including blood, saliva, excreta, body tissue and tissue fluids, and also FDA-approved pharmaceuticals that are blood products. In medical contexts, it is a specimen taken for diagnostic examination or evaluation, and for identification of disease or condition. Methods of sampling of body fluids include: A relatively new trend in contemporary art is to use body fluids in